metoclopramide has been researched along with Cochlear Hearing Loss in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buscaglia, J | 1 |
| Faris, J | 1 |
| Satar, B | 1 |
| Hidir, Y | 1 |
| Yetiser, S | 1 |
2 other studies available for metoclopramide and Cochlear Hearing Loss
| Article | Year |
|---|---|
Unsteady, unfocused, and unable to hear.
Topics: Adolescent; Cognition Disorders; Combined Modality Therapy; Female; Fluid Therapy; Gait Disorders, N | 2005 |
Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss.
Topics: Adult; Aged; Aged, 80 and over; Audiometry, Pure-Tone; Chi-Square Distribution; Chlorpheniramine; Co | 2006 |